Cargando…
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis
BACKGROUND: Cognitive dysfunction and brain atrophy are both common in progressive multiple sclerosis (MS) but are seldom examined comprehensively in clinical trials. Antioxidant treatment may affect the neurodegeneration characteristic of progressive MS and slow its symptomatic and radiographic cor...
Autores principales: | Spain, Rebecca I., Hildebrand, Andrea, Waslo, Carin S., Rooney, William D., Emmons, Joshua, Schwartz, Daniel L., Freedman, Mark S., Paz Soldan, M. Mateo, Repovic, Pavle, Solomon, Andrew J., Rinker, John, Wallin, Mitchell, Haselkorn, Jodie K., Stuve, Olaf, Gross, Robert H., Turner, Aaron P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285490/ https://www.ncbi.nlm.nih.gov/pubmed/37360346 http://dx.doi.org/10.3389/fneur.2023.1188124 |
Ejemplares similares
-
Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19
por: Shin, Robert K., et al.
Publicado: (2022) -
Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations
por: Stuve, Olaf, et al.
Publicado: (2020) -
Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population
por: Abbatemarco, Justin R., et al.
Publicado: (2021) -
MRI brain volume loss, lesion burden, and clinical outcome in
secondary progressive multiple sclerosis
por: Koch, Marcus W, et al.
Publicado: (2021) -
Impact of clinical outcomes and imaging measures on health-related
quality of life in secondary progressive MS
por: W Koch, Marcus, et al.
Publicado: (2021)